FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3883511000001107: Starlix 180mg tablets (Novartis Pharmaceuticals UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17987901000001111 Starlix 180mg tablets (Novartis Pharmaceuticals UK Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17988001000001113 Starlix 180mg tablets (Novartis Pharmaceuticals UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Starlix 180mg tablets (Novartis Pharmaceuticals UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Starlix 180mg tablets (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Starlix 180mg tablets (Novartis Pharmaceuticals UK Ltd) Is a Product containing precisely nateglinide 180 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Starlix 180mg tablets (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Starlix 180mg tablets (Novartis Pharmaceuticals UK Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Starlix 180mg tablets (Novartis Pharmaceuticals UK Ltd) Has active ingredient Nateglinide false Inferred relationship Existential restriction modifier
Starlix 180mg tablets (Novartis Pharmaceuticals UK Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Starlix 180mg tablets (Novartis Pharmaceuticals UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Starlix 180mg tablets (Novartis Pharmaceuticals UK Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Starlix 180mg tablets (Novartis Pharmaceuticals UK Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Starlix 180mg tablets (Novartis Pharmaceuticals UK Ltd) Is a Starlix true Inferred relationship Existential restriction modifier
Starlix 180mg tablets (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient Nateglinide true Inferred relationship Existential restriction modifier
Starlix 180mg tablets (Novartis Pharmaceuticals UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Starlix 180mg tablets (Novartis Pharmaceuticals UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Starlix 180mg tablets (Novartis Pharmaceuticals UK Ltd) 84 tablet 7 x 12 tablets Is pack of False Starlix 180mg tablets (Novartis Pharmaceuticals UK Ltd) Inferred relationship Existential restriction modifier
Starlix 180mg tablets (Novartis Pharmaceuticals UK Ltd) 84 tablet 7 x 12 tablets Has AMP True Starlix 180mg tablets (Novartis Pharmaceuticals UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start